APPLICATION
ANDA075276
TYPE
ANDA
ORIGINAL APPROVAL
2003-05-13
LATEST ACTION
2004-07-22
ROUTE
TOPICAL
DOSAGE FORM
GEL, AUGMENTED
MARKETING STATUS
Prescription
Products
BETAMETHASONE DIPROPIONATEPrescription
BETAMETHASONE DIPROPIONATE EQ 0.05% BASE · GEL, AUGMENTED · TOPICAL
Approval history
2004-07-22Labeling · Supplement 6AP
2004-06-16Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.